- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03460639
Administration of Low-level Laser on Muscles of Mastication Following the Induction of Initial Fatigue
March 7, 2018 updated by: Greice de Brito Bitencourt, University of Nove de Julho
Orofacial pain encompasses painful conditions, such as temporomandibular disorder.
Multidisciplinary health teams seek to control such musculoskeletal disorders to improve the quality and functional capacity of the muscles of mastication.
The aim of the proposed study is to evaluate the effect of low-level laser therapy as a form of treatment for the prevention of initial fatigue of the muscles of mastication (masseter and anterior temporal muscles) as well as the recovery of these muscles after induced exhaustion (caused by isometric contraction) in young adults.
The participants will be 78 (n obtained from calculation of the sample size with p < 0.05) healthy male and female volunteers between 18 and 34 years of age.
The volunteers will be randomly allocated to a laser group (n = 26), sham group (n = 26) and control group (n = 26).
All participants will be submitted to a clinical evaluation to record mandibular movements, bite force, muscle sensitivity to palpation and initial muscle fatigue.
Initial fatigue will be induced by isometric contraction of the jaws.
Maximum voluntary contraction will be performed to record the time until initial exhaustion of the masseter muscle (determined by electromyography).
The groups will then be submitted to the interventions: 1) active laser therapy (wavelength: 780 nm; fluence: 134 J/cm2; power: 50 mW; irradiance: 1.675 W/cm2; exposure time: 80 seconds per point) on three points of the masseter and one point on the anterior temporal muscles on each side, 2) sham laser (placebo effect) or 3) no intervention (control).
Maximum voluntary contraction will be performed again after the interventions to record the time until initial exhaustion of the masseter muscle (determined by electromyography).
Differences in individual time until exhaustion between the pre-intervention and post-intervention evaluations will be measured to determine the effect of low-level laser therapy.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
78
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Greice B Bitencourt, MS
- Phone Number: 5511998359996
- Email: greicebrito@hotmail.com
Study Locations
-
-
SP
-
São Paulo, SP, Brazil, 01504001
- Recruiting
- University Nove de Julho
-
Contact:
- Greice B Bitercourt, MS
- Phone Number: 5511998359996
- Email: greicebrito@hotmail.com
-
Sub-Investigator:
- Sandra K Bussadori, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 34 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- will be included in this study young people in the age range between 18-34 years, without diagnosis of temporomandibular disorder (TMD) and with the signed free informed consent term.
Exclusion Criteria:
- will be excluded from the study individuals who are in orthodontic or orthopedic treatment of the jaw, psychological and / or physiotherapy. Also excluded are those who are taking anti-inflammatory drugs and anti-inflammatory drugs and occlusal plaques.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Active laser
Three points on the masseter muscle (upper, middle and lower portions) and one point on the anterior temporal on each side of the face will be irradiated with a wavelength of 780 nm, radiant exposure of 134 J/cm2, power of 50 mW and irradiance of 1.675 W/cm2 for 80 seconds per point, resulting in an energy of 4 J per point and total energy of 32 J per volunteer.20,21
Point application will be performed with a conventional tip in contact with the skin (beam spot: 0.04 cm2).
|
Three points on the masseter muscle (upper, middle and lower portions) and one point on the anterior temporal on each side of the face will be irradiated with a wavelength of 780 nm, radiant exposure of 134 J/cm2, power of 50 mW and irradiance of 1.675 W/cm2 for 80 seconds per point, resulting in an energy of 4 J per point and total energy of 32 J per volunteer.20,21
Point application will be performed with a conventional tip in contact with the skin (beam spot: 0.04 cm2).
|
Sham Comparator: Sham laser
The same procedures will be performed in the sham group, but the device will be switched off and a recording of the emission sounds will be used to give the volunteer the auditory sensation of laser therapy.
|
The same procedures will be performed in the sham group, but the device will be switched off and a recording of the emission sounds will be used to give the volunteer the auditory sensation of laser therapy.
|
Other: Control group
In this group, no treatment will be done, we will only induce fatigue, for evaluation.
|
In this group, we will only induce fatigue.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of the masseter muscle strength determined by electromyography before and after treatment
Time Frame: Before and immediately after treatment
|
MVC (clenching the teeth in maximum intercuspation) will be performed to record the time until initial exhaustion of the masseter muscle (determined by electromyography).
The groups will then be submitted to the interventions and MVC will be performed a second time to record the time until initial exhaustion of the masseter muscle (determined by electromyography).
During the procedures, the volunteers will receive verbal encouragement as well as visual feedback on the monitor to maintain MVC.
Before the readings, the volunteers will undergo training of the procedure for the acquisition of the EMG signal.
|
Before and immediately after treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 20, 2017
Primary Completion (Anticipated)
April 1, 2018
Study Completion (Anticipated)
July 1, 2018
Study Registration Dates
First Submitted
December 5, 2017
First Submitted That Met QC Criteria
March 7, 2018
First Posted (Actual)
March 9, 2018
Study Record Updates
Last Update Posted (Actual)
March 9, 2018
Last Update Submitted That Met QC Criteria
March 7, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 919822905
- 290582 (Other Identifier: uninove)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Fatigue
-
University of TorontoCompleted
-
University of British ColumbiaCompletedMuscle Fatigue | Muscle PowerCanada
-
University of Nove de JulhoFundação de Amparo à Pesquisa do Estado de São PauloCompletedMuscle; Fatigue, Heart | Skeletal Muscle RecoveryBrazil
-
Universidade AnhangueraUniversidade Federal de Sao CarlosRecruitingMuscle; Fatigue, Heart | Muscle Damage | LaserBrazil
-
University of Nove de JulhoFundação de Amparo à Pesquisa do Estado de São PauloCompletedMuscle; Fatigue, Heart | Skeletal Muscle RecoveryBrazil
-
Metabolic Technologies Inc.University of TampaCompletedMuscle Fatigue Caused by Repetitive Muscle ExerciseUnited States
-
University of Applied Sciences for Health Professions...University of Wisconsin, MilwaukeeCompleted
-
Taoyuan General HospitalCompleted
-
Alaa Yousri Mahmoud AtiaUnknownMuscle FatigueEgypt
-
Swiss Federal Institute of TechnologyUniversity of Michigan; University of Lausanne; University of Turin, ItalyCompletedMuscle Fatigue | Trapezius Muscle Strain
Clinical Trials on Active laser
-
Universidade Norte do ParanáUniversidade Estadual de LondrinaCompletedPerformance | Aged | Muscle Strength | Resistance Training | LasersBrazil
-
Universidade Cidade de Sao PauloCompleted
-
Uppsala UniversityUnknown
-
William Beaumont HospitalsWithdrawnUrinary Incontinence | Stress Urinary IncontinenceUnited States
-
University of Texas Southwestern Medical CenterTerminated
-
University of Texas Southwestern Medical CenterTerminatedChronic PainUnited States
-
Maharishi Markendeswar University (Deemed to be...Completed
-
Nova Eye Medical Pty Ltd.Centre for Eye Research AustraliaRecruitingCentral Serous ChorioretinopathyAustralia
-
Cairo UniversityRecruitingSystemic Lupus Erythematosus | PreDiabetesEgypt
-
Erika Carmel ltdHoly Family Hospital, Nazareth, IsraelRecruiting